Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001213900-24-046302
Filing Date
2024-05-23
Accepted
2024-05-23 16:41:19
Documents
66
Period of Report
2024-03-31

Document Format Files

Seq Description Document Type Size
1 QUARTERLY REPORT ea0206597-10q_gamidacell.htm   iXBRL 10-Q 1079993
2 CERTIFICATION ea020659701ex31-1_gamida.htm EX-31.1 16808
3 CERTIFICATION ea020659701ex31-2_gamida.htm EX-31.2 9464
4 CERTIFICATION ea020659701ex32-1_gamida.htm EX-32.1 4593
  Complete submission text file 0001213900-24-046302.txt   4979759

Data Files

Seq Description Document Type Size
5 XBRL SCHEMA FILE gmda-20240331.xsd EX-101.SCH 54366
6 XBRL CALCULATION FILE gmda-20240331_cal.xml EX-101.CAL 30967
7 XBRL DEFINITION FILE gmda-20240331_def.xml EX-101.DEF 211841
8 XBRL LABEL FILE gmda-20240331_lab.xml EX-101.LAB 452950
9 XBRL PRESENTATION FILE gmda-20240331_pre.xml EX-101.PRE 211914
70 EXTRACTED XBRL INSTANCE DOCUMENT ea0206597-10q_gamidacell_htm.xml XML 442676
Mailing Address 5 NAHUM HAFZADI STREET JERUSALEM L3 95484
Business Address 5 NAHUM HAFZADI STREET JERUSALEM L3 95484 97226595666
Gamida Cell Ltd. (Filer) CIK: 0001600847 (see all company filings)

EIN.: 000000000 | State of Incorp.: L3 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38716 | Film No.: 24979000
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)